These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Non-fucosylated CB CD34 Robinson SN; Thomas MW; Simmons PJ; Lu J; Yang H; Javni JA; Shpall EJ; Zweidler-Mckay PA Cytotherapy; 2017 Feb; 19(2):285-292. PubMed ID: 27919572 [TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912 [TBL] [Abstract][Full Text] [Related]
24. CH02 peptide promotes Yang Y; Zhang B; Xie J; Li J; Liu J; Liu R; Zhang L; Zhang J; Su Z; Li F; Zhang L; Hong A; Chen X Acta Biochim Biophys Sin (Shanghai); 2023 Oct; 55(10):1630-1639. PubMed ID: 37381672 [TBL] [Abstract][Full Text] [Related]
25. Clinical Progress and Preclinical Insights Into Umbilical Cord Blood Transplantation Improvement. Sun Z; Yao B; Xie H; Su X Stem Cells Transl Med; 2022 Sep; 11(9):912-926. PubMed ID: 35972332 [TBL] [Abstract][Full Text] [Related]
26. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Forraz N; Pettengell R; McGuckin CP Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396 [TBL] [Abstract][Full Text] [Related]
27. Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy. Panch SR; Szymanski J; Savani BN; Stroncek DF Biol Blood Marrow Transplant; 2017 Aug; 23(8):1241-1249. PubMed ID: 28495640 [TBL] [Abstract][Full Text] [Related]
28. Study of stem cell homing & self-renewal marker gene profile of Kode J; Khattry N; Bakshi A; Amrutkar V; Bagal B; Karandikar R; Rane P; Fujii N; Chiplunkar S Indian J Med Res; 2017 Jul; 146(1):56-70. PubMed ID: 29168461 [TBL] [Abstract][Full Text] [Related]
29. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887 [TBL] [Abstract][Full Text] [Related]
30. Three-Dimensional Co-culture of Human Hematopoietic Stem/Progenitor Cells and Mesenchymal Stem/Stromal Cells in a Biomimetic Hematopoietic Niche Microenvironment. Costa MHG; Monteiro TS; Cardoso S; Cabral JMS; Ferreira FC; da Silva CL Methods Mol Biol; 2019; 2002():101-119. PubMed ID: 30367359 [TBL] [Abstract][Full Text] [Related]
31. Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation. Aljitawi OS; Paul S; Ganguly A; Lin TL; Ganguly S; Vielhauer G; Capitano ML; Cantilena A; Lipe B; Mahnken JD; Wise A; Berry A; Singh AK; Shune L; Lominska C; Abhyankar S; Allin D; Laughlin M; McGuirk JP; Broxmeyer HE Blood; 2016 Dec; 128(25):3000-3010. PubMed ID: 27760758 [TBL] [Abstract][Full Text] [Related]
32. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Zheng Y; Watanabe N; Nagamura-Inoue T; Igura K; Nagayama H; Tojo A; Tanosaki R; Takaue Y; Okamoto S; Takahashi TA Exp Hematol; 2003 Dec; 31(12):1237-46. PubMed ID: 14662330 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells. Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960 [TBL] [Abstract][Full Text] [Related]
34. Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation. Horwitz ME; Frassoni F Cytotherapy; 2015 Jun; 17(6):730-738. PubMed ID: 25778757 [TBL] [Abstract][Full Text] [Related]
35. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Hofmeister CC; Zhang J; Knight KL; Le P; Stiff PJ Bone Marrow Transplant; 2007 Jan; 39(1):11-23. PubMed ID: 17164824 [TBL] [Abstract][Full Text] [Related]
36. Human Bone Marrow Mesenchymal Stromal Cell-Derived Osteoblasts Promote the Expansion of Hematopoietic Progenitors Through Beta-Catenin and Notch Signaling Pathways. Michalicka M; Boisjoli G; Jahan S; Hovey O; Doxtator E; Abu-Khader A; Pasha R; Pineault N Stem Cells Dev; 2017 Dec; 26(24):1735-1748. PubMed ID: 29050516 [TBL] [Abstract][Full Text] [Related]
37. Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells. Zhai QL; Qiu LG; Li Q; Meng HX; Han JL; Herzig RH; Han ZC Haematologica; 2004 Mar; 89(3):265-73. PubMed ID: 15020263 [TBL] [Abstract][Full Text] [Related]
38. Extensive immunophenotypic sub-population analysis of StemRegenin1 expanded haematopoietic stem/progenitor cells. Mellet J; Hendricks CL; Stivaktas V; Durandt C; Ambele MA; Pepper MS Stem Cell Res Ther; 2024 Sep; 15(1):317. PubMed ID: 39304924 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic. Faivre L; Parietti V; Siñeriz F; Chantepie S; Gilbert-Sirieix M; Albanese P; Larghero J; Vanneaux V Stem Cell Res Ther; 2016 Jan; 7():3. PubMed ID: 26742480 [TBL] [Abstract][Full Text] [Related]
40. Scalable Manufacturing of Human Hematopoietic Stem/Progenitor Cells Exploiting a Co-culture Platform with Mesenchymal Stromal Cells. Fernandes-Platzgummer A; Andrade PZ; Cabral JMS; da Silva CL Methods Mol Biol; 2021; 2286():107-120. PubMed ID: 32488668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]